CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

113 hedge funds and large institutions have $399M invested in CytomX Therapeutics in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
+2
Holders Change %
+1.8%
% of All Funds
2.45%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
45
Reduced
34
Closed
14
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
-$172K

Top Buyers

1
BI
BVF Inc
California
$12.9M
2
GPP
Great Point Partners
Connecticut
$10.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
$25.9M
4
Victory Capital Management
Victory Capital Management
Texas
$17.8M
5
Wellington Management Group
Wellington Management Group
Massachusetts
$35.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$23M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$33.2M
3
DM
Deerfield Management
New York
$0
4
Point72 Asset Management
Point72 Asset Management
Connecticut
$6.73M
5
Fidelity International
Fidelity International
Bermuda
$1.21M
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of Montreal
126
Bank of Montreal
Ontario, Canada
– -$13K -853 Closed
AWMS
127
Advocacy Wealth Management Services
Georgia
– -$2K -100 Closed
2 3 4 5
6